Cantel Medical (CMD) Earning Somewhat Positive Press Coverage, Analysis Shows

News stories about Cantel Medical (NYSE:CMD) have trended somewhat positive this week, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cantel Medical earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave media coverage about the company an impact score of 43.7575838090641 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:

How to Become a New Pot Stock Millionaire

Shares of NYSE:CMD opened at $115.24 on Friday. Cantel Medical has a 12-month low of $69.21 and a 12-month high of $123.60. The stock has a market cap of $4,838.82, a PE ratio of 55.40 and a beta of 1.26. The company has a current ratio of 2.58, a quick ratio of 1.57 and a debt-to-equity ratio of 0.27.

Cantel Medical (NYSE:CMD) last announced its quarterly earnings data on Thursday, March 8th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.58 by $0.01. Cantel Medical had a return on equity of 17.18% and a net margin of 10.92%. The firm had revenue of $213.03 million for the quarter, compared to analysts’ expectations of $210.60 million. analysts anticipate that Cantel Medical will post 2.5 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by Week Herald and is the property of of Week Herald. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at

About Cantel Medical

Cantel Medical Corp. provides infection prevention products and services for the healthcare market worldwide. The company operates through four segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

Insider Buying and Selling by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with's FREE daily email newsletter.

Leave a Reply